Paper25965833
Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
Leach DA and 18 others. Oncotarget, 2015. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome. Papers, record 25965833. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25965833
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics32
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myofibroblasts | Major topic |
| Prostatic Hyperplasia | Major topic |
| Prostatic Neoplasms | Major topic |
| Receptors, Androgen | Major topic |
| Stromal Cells | Major topic |
| Tumor Microenvironment | Major topic |
| Aged | |
| Aged, 80 and over | |
| Androgens | |
| Animals | |
| Apoptosis | |
| Blotting, Western | |
| Case-Control Studies | |
| Cell Adhesion | |
| Cell Movement | |
| Cell Proliferation | |
| Chromatin Immunoprecipitation | |
| Follow-Up Studies | |
| Humans | |
| Immunoenzyme Techniques | |
| Male | |
| Middle Aged | |
| Neoplasm Grading | |
| Neoplasm Invasiveness | |
| Orchiectomy | |
| Prognosis | |
| RNA, Messenger | |
| Real-Time Polymerase Chain Reaction | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Signal Transduction | |
| Tissue Array Analysis | |
| Tumor Cells, Cultured |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U01 CA149556 | NCI NIH HHS | United States | U01CA149556 | PubMed and NIH |
| 1U01CA149556-01 | NCI NIH HHS | United States | U01CA149556 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 26577649 | Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome. | https://conductscience.org/library/papers/26577649 |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12231536 | Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. | Clin Cancer Res | 2002 | https://conductscience.org/library/papers/12231536 | PubMed |
| 2 | 20080664 | Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20080664 | PubMed |
| 3 | 15369448 | Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. | Endocr Relat Cancer | 2004 | https://conductscience.org/library/papers/15369448 | PubMed |
| 4 | 14764882 | TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. | Science | 2004 | https://conductscience.org/library/papers/14764882 | PubMed |
| 5 | 21244824 | Elucidating the role of matrix stiffness in 3D cell migration and remodeling. | Biophys J | 2011 | https://conductscience.org/library/papers/21244824 | PubMed |
| 6 | 21267466 | Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells. | PLoS One | 2011 | https://conductscience.org/library/papers/21267466 | PubMed |
| 7 | 21303979 | Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. | Cancer Res | 2011 | https://conductscience.org/library/papers/21303979 | PubMed |
| 8 | 21153687 | Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides. | Clin Exp Metastasis | 2011 | https://conductscience.org/library/papers/21153687 | PubMed |
| 9 | 21474781 | Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21474781 | PubMed |
| 10 | 21611158 | Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer. | PLoS One | 2011 | https://conductscience.org/library/papers/21611158 | PubMed |
| 11 | 21674698 | Brief report: a bioassay to identify primary human prostate cancer repopulating cells. | Stem Cells | 2011 | https://conductscience.org/library/papers/21674698 | PubMed |
| 12 | 22388175 | Extracellular matrix secreted by reactive stroma is a main inducer of pro-tumorigenic features on LNCaP prostate cancer cells. | Cancer Lett | 2012 | https://conductscience.org/library/papers/22388175 | PubMed |
| 13 | 22593016 | Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status. | Stem Cells | 2012 | https://conductscience.org/library/papers/22593016 | PubMed |
| 14 | 22693264 | Subdomain structure of the co-chaperone SGTA and activity of its androgen receptor client. | J Mol Endocrinol | 2012 | https://conductscience.org/library/papers/22693264 | PubMed |
| 15 | 22535887 | Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis. | Carcinogenesis | 2012 | https://conductscience.org/library/papers/22535887 | PubMed |
| 16 | 22745041 | Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines. | EMBO Mol Med | 2012 | https://conductscience.org/library/papers/22745041 | PubMed |
| 17 | 22911669 | Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug. | J Natl Cancer Inst | 2012 | https://conductscience.org/library/papers/22911669 | PubMed |
| 18 | 22930558 | The reactive stroma microenvironment and prostate cancer progression. | Endocr Relat Cancer | 2012 | https://conductscience.org/library/papers/22930558 | PubMed |
| 19 | 23558784 | A preclinical xenograft model of prostate cancer using human tumors. | Nat Protoc | 2013 | https://conductscience.org/library/papers/23558784 | PubMed |
| 20 | 23562048 | A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer. | Biomaterials | 2013 | https://conductscience.org/library/papers/23562048 | PubMed |
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41684004 | Prostate Cancer-Associated Fibroblasts: A Review on CAF Functions, Heterogeneity, Resistance Mechanisms, and Future in a Chip. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41684004 | PubMed |
| 40802773 | Transcriptome fingerprinting of aberrant fibroblast activation unlocks effective therapeutics to tackle cardiac fibrosis. | Sci Adv | 2025 | https://conductscience.org/library/papers/40802773 | PubMed |
| 40411304 | Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis. | Mol Oncol | 2025 | https://conductscience.org/library/papers/40411304 | PubMed |
| 39335188 | Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39335188 | PubMed |
| 38863718 | Sex differences in cancer and immunotherapy outcomes: the role of androgen receptor. | Front Immunol | 2024 | https://conductscience.org/library/papers/38863718 | PubMed |
| 38769192 | AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production. | Oncogene | 2024 | https://conductscience.org/library/papers/38769192 | PubMed |
| 38191471 | Distinct mesenchymal cell states mediate prostate cancer progression. | Nat Commun | 2024 | https://conductscience.org/library/papers/38191471 | PubMed |
| 37435460 | Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer. | Endocr Oncol | 2022 | https://conductscience.org/library/papers/37435460 | PubMed |
| 37192413 | Cancer Cell-Extrinsic Roles for the Androgen Receptor in Prostate Cancer. | Endocrinology | 2023 | https://conductscience.org/library/papers/37192413 | PubMed |
| 37170459 | Inflammatory response to Trichomonas vaginalis in the pathogenesis of prostatitis and benign prostatic hyperplasia. | Parasites Hosts Dis | 2023 | https://conductscience.org/library/papers/37170459 | PubMed |
| 37073437 | Cell-by-cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression. | J Pathol Clin Res | 2023 | https://conductscience.org/library/papers/37073437 | PubMed |
| 36769153 | Early Cell Cultures from Prostate Cancer Tissue Express Tissue Specific Epithelial and Cancer Markers. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36769153 | PubMed |
| 36671452 | Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer. | Biomolecules | 2022 | https://conductscience.org/library/papers/36671452 | PubMed |
| 36612143 | Activin B and Activin C Have Opposing Effects on Prostate Cancer Progression and Cell Growth. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36612143 | PubMed |
| 36551674 | Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36551674 | PubMed |
| 35613593 | Stromal AR inhibits prostate tumor progression by restraining secretory luminal epithelial cells. | Cell Rep | 2022 | https://conductscience.org/library/papers/35613593 | PubMed |
| 34692685 | The Role of Androgen Receptor in Cross Talk Between Stromal Cells and Prostate Cancer Epithelial Cells. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34692685 | PubMed |
| 34328182 | Roles of steroid receptors in the lung and COVID-19. | Essays Biochem | 2021 | https://conductscience.org/library/papers/34328182 | PubMed |
| 33500395 | The androgen receptor/filamin A complex as a target in prostate cancer microenvironment. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33500395 | PubMed |
| 33458399 | Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features. | Phys Imaging Radiat Oncol | 2018 | https://conductscience.org/library/papers/33458399 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25965833
GET https://conductscience.org/api/papers/v1/25965833/references?page=2